Clinical and radiographic evaluation of vital pulp therapy in open apex teeth with MTA and ZOE.
Abstract
The purpose of this study was to report the success rate of using mineral trioxide aggregate (MTA) and zinc oxide eugenol (ZOE) as vital pulp therapy agents in immature permanent teeth with carious or traumatic pulp exposure. Subjects were children with permanent teeth requiring pulpotomy (apexogenesis) and without systemic diseases. Both ZOE and MTA treatments as pulpotomy agents showed clinical and radiographic success in immature permanent teeth. Although MTA was more successful, it is more expensive, and dentin bridges may develop over canal orifices, complicating future root canal therapy.
Links
Authors
Ghoddusi J, Shahrami F, Alizadeh M, Kianoush K, Forghani M
Institution
Dental Research Center, Faculty of Dentistry, Mashhad University of Medical Sciences, Iran. ghoddusij@mums.ac.ir
Source
The New York state dental journal 78:3 2012 Apr pg 34-8MeSH
Aluminum CompoundsCalcium Compounds
Child
Dental Pulp Capping
Drug Combinations
Humans
Oxides
Prospective Studies
Pulp Capping and Pulpectomy Agents
Pulpitis
Pulpotomy
Retrospective Studies
Silicates
Tooth Apex
Zinc Oxide-Eugenol Cement
Pub Type(s)
Journal ArticleRandomized Controlled Trial
Language
eng
PubMed ID
22803275
Log In

